申请人:Eggenweiler Hans-Michael
公开号:US20100113542A1
公开(公告)日:2010-05-06
5-[4-(2-Methylphenyl)-3-hydroxy-4H-1,2,4-triazol-5-yl]-2,4-dihydroxy-N-methyl-N-butylbenzamide is an HSP90 inhibitor and can be used for the preparation of a medicament for the treatment of diseases in which the inhibition, regulation and/or modulation of HSP90 plays a role.
5-[4-(2-甲基苯基)-3-羟基-4H-1,2,4-三唑-5-基]-2,4-二羟基-N-甲基-N-丁基苯甲酰胺是一种HSP90抑制剂,可用于制备用于治疗HSP90在其中起作用的疾病的药物。